saxagliptin Pages on BioPortfolio:

BioPortfolio - saxagliptin
18 Jun 2008 ... Biotechnology News new drug class saxagliptin. minnick. 5135. ... 18.16.1 Saxagliptin 18.17 Research Pipeline for Boehringer Ingelheim . ...
http://www.bioportfolio.com/search/saxagliptin.html...

BioPortfolio - postcodes in texas
BioPortfolio - postcodes in Dallas US in texas | postcodes in Dallas US | POSTCODE FOR TEXAS | saxagliptin | dallas texas postcode . ...
http://www.bioportfolio.com/search/postcodes_in_texas.html...

BioPortfolio - postcode ohio
BioPortfolio - find the postcode of texas Bioportfolio - ohio postcodes . ... in texas | postcodes in Dallas US | POSTCODE FOR TEXAS | saxagliptin | dallas ...
http://www.bioportfolio.com/search/postcode_ohio.html...

BioPortfolio - Boehringer Ingelheim GmbH dpp-4
BioPortfolio - Boehringer Ingelheim GmbH dpp-4 18.16.1 Saxagliptin 18.17 Research Pipeline for ... http://www.bioportfolio.com/search/saxagliptin.html.
...
http://www.bioportfolio.com/search/Boehringer_Ingelheim_GmbH...

Results from other life science and pharmaceutical sites:

Saxagliptin Once Daily Improves Key Clinical Measures of Glucose ...
9 Jun 2008 ... By preventing the cleavage of glucagon-like peptide 1, saxagliptin preserves multiple mechanisms that regulate blood glucose.
http://www.medscape.com/viewarticle/575750...

New Data for Investigational Diabetes Drug Saxagliptin ...
9 Sep 2008 ... New Data for Investigational Diabetes Drug Saxagliptin Demonstrates Potential for Type 2 Diabetes Treatment.
http://biz.yahoo.com/prnews/080909/3735782en_public.html?.v=...

News: ONGLYZA(TM) (saxagliptin) With Metformin as Initial ...
9 Sep 2008 ... ONGLYZA(TM) (saxagliptin) With Metformin as Initial Combination Therapy Significantly Lowered A1C and Demonstrated Significant Improvements ...
http://www.genengnews.com/news/bnitem.aspx?name=41536735...

ONGLYZA(TM) (saxagliptin) Demonstrated Significant Improvements ...
ONGLYZA(TM) (saxagliptin) Demonstrated Significant Improvements Across Key Measures of Glucose Control When Added to a Sulfonylurea or Thiazolidinedione in
...
http://biz.yahoo.com/bw/080908/20080908005647.html?.v=1...

Discovery and preclinical profile of Saxagliptin (...[J Med Chem ...
Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the ...
http://www.ncbi.nlm.nih.gov/pubmed/16033281...

Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic ...
This was the first time that Phase III data for saxagliptin have been presented in a scientific setting. A group of 743 subjects (ages 18-77) with Type 2 ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Glucose-lowering activity of the dipeptidyl peptid...[Diabetes ...
The aim of this study was to evaluate the safety and efficacy of dose ranges of the DPP-4 inhibitor saxagliptin (BMS-477118) in patients with T2DM. ...
http://www.ncbi.nlm.nih.gov/pubmed/18355324...

Bristol-Myers Squibb Company, AstraZeneca PLC Meet Study Goal ...
9 Sep 2008 ... About the Study The study was designed to assess saxagliptin as an ... Study Results After 24 weeks, individuals in the saxagliptin + ...
http://www.biospace.com/news_story.aspx?NewsEntityId=109059...

Glucose-lowering activity of the dipeptidyl peptid...[Diabetes ...
In a second cohort, patients received saxagliptin 100 mg once daily, ... The main outcome measure was saxagliptin dose response assessed as change from ...
http://www.ncbi.nlm.nih.gov/pubmed/18355324/...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.